Remove 2006 Remove Cannabinoids Remove DEA Remove Patients
article thumbnail

CBD, THC, AND CANCER

Weedistry

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find.

THC 40
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Substances derived from the cannabis plant include marijuana, hemp, and cannabinoids. Executive Summary.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 9, 2006 , 120 Stat. 201, July 27, 2006 , 120 Stat.

Banking 45